Guangdong Engineering Research Center of Natural Products and New Drugs, Guangdong Provincial University Engineering Technology Research Center of Natural Products and Drugs , Guangdong Pharmaceutical University , Guangzhou 510006 , China.
Guangdong Metabolic Diseases Research Centre of Integrated Chinese and Western Medicine , Guangdong Pharmaceutical University , Guangzhou 510006 , China.
J Agric Food Chem. 2020 Jan 8;68(1):4-16. doi: 10.1021/acs.jafc.9b06079. Epub 2019 Dec 27.
Obesity has an important influence on health conditions, causing a multitude of complications and comorbidities, and drug therapy is considered to be one of the treatment strategies. Nowadays, there is increasing interest in the study of intestinal microbiota regulation of obesity; also, an increasing number of agricultural and sideline products have been found to have anti-obesity potential. In the present review, we summarize an overview of current known and potential anti-obesity oligosaccharides and their molecular structures. We describe their anti-obesity potential activity and the molecular structure associated with this activity, the regulation of intestinal microbiota composition and its mechanism of action, including regulation of the short-chain fatty acid (SCFA) pathway and altering bile acid (BA) pathway. This review will provide new ideas for us to develop new anti-obesity functional foods.
肥胖对健康状况有重要影响,会导致多种并发症和合并症,药物治疗被认为是治疗策略之一。如今,人们对肠道微生物群调节肥胖的研究越来越感兴趣;同时,越来越多的农产品和副业产品被发现具有抗肥胖的潜力。在本综述中,我们总结了目前已知和潜在的抗肥胖低聚糖及其分子结构的概述。我们描述了它们的抗肥胖活性及其与该活性相关的分子结构、对肠道微生物群组成的调节及其作用机制,包括调节短链脂肪酸(SCFA)途径和改变胆汁酸(BA)途径。这篇综述将为我们开发新的抗肥胖功能性食品提供新的思路。